Metabolic syndrome is not associated with greater evidences of proliferative inflammatory atrophy and inflammation in patients with suspected prostate cancer

To evaluate the association between metabolic syndrome (MetS) and proliferative inflammatory atrophy (PIA) in patients with suspected prostate cancer (PCa).

Source: Urologic Oncology: Seminars and Original Investigations - February 8, 2018 Category: Urology & Nephrology Authors: Giorgio I. Russo, Sebastiano Cimino, Giorgia Giranio, Federica Regis, Vincenzo Favilla, Salvatore Privitera, Fabio Motta, Rosario Caltabiano, Arnulf Stenzl, Tilman Todenh öfer, Giuseppe Morgia Tags: Original article Source Type: research